INOVIO Pharma plans public offering of common stock and warrants
From Nasdaq.: 2025-07-02 22:31:00
INOVIO Pharmaceuticals Inc. is planning a public offering to sell shares of its common stock, along with Series A and Series B warrants to purchase shares. The underwriter will have the option to purchase additional shares and warrants up to 15% of the offering. Piper Sandler & Co. is the sole book-running manager for the offering.
Read more at Nasdaq.: INOVIO Pharma Announces Proposed Public Offering